• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Study Reveals Distinct Outcomes in Younger Patients With Grade 3 Oligodendroglioma

by MM360 Staff | May 19, 2025 | Uncategorized

Source: CureToday articles Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients, a study found. Read More

Fatigue, Sleep and Urinary Symptoms Affect Cognition in Prostate Cancer

by MM360 Staff | May 18, 2025 | Uncategorized

Source: CureToday articles Managing fatigue, sleep, urinary symptoms and depression is key to improving cognitive function in those receiving radiation therapy for prostate cancer. Read More

Providing Care and Listening With Compassion During Cancer

by MM360 Staff | May 18, 2025 | Uncategorized

Source: CureToday articles Post Content Read More

Tagrisso Therapy Elicits Wave of New Therapeutic Approaches in NSCLC

by MM360 Staff | May 17, 2025 | Uncategorized

Source: CureToday articles Dr. Suresh Ramalingam discussed how the LAURA findings support the role of Tagrisso as a backbone therapy across multiple settings in EGFR-mutated NSCLC. Read More

Cancer Didn’t Break Me; It Revealed My Strength

by MM360 Staff | May 17, 2025 | Uncategorized

Source: CureToday articles I’m a single mom with chronic lymphocytic leukemia sharing how cancer tested me but revealed my resilience, hardship and the power of speaking up. Read More

2025 Quarter 1 – COA Patient Advocacy Network News Bulletin.

by MM360 Staff | May 16, 2025 | Uncategorized

Source: CureToday articles Enclosed is the 2025 Quarter 1 – COA Patient Advocacy Network News Bulletin. Read More
« Older Entries
Next Entries »

Recent Content

  • In vivo CAR-T exhibits activity in advanced multiple myeloma
  • FDA backs faster development of new therapy for hard-to-treat AML
  • The efficacy and safety of anti-CD38 monoclonal antibodies in transplant-ineligible newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials
  • Predictive values of baseline 18F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapy
  • Correction: Chen et al. The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis. Diagnostics 2024, 14, 1030
  • Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials
  • Combo treatment may offer new hope to astrocytoma patients: Trial
  • Reduced-versus Standard-dose Melphalan as Single-agent Conditioning Regimen in Auto HSCT for Multiple Myeloma: A Systematic Review and Meta-Analysis
  • Dosing begins in trial testing Enhertu for ovarian cancer
  • (no title)
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT